Navigation Links
Retina Specialty Institute Gives Patients Something to Look Forward to in Crestview

Crestview, FL (PRWEB) January 21, 2013

Retina Specialty Institute is opening a new office location in Crestview, Fla. to help treat patients suffering from Age-Related Macular Degeneration (AMD), Diabetic Retinopathy and other vision-threatening retinal diseases. Retina Specialty Institute is a national, FDA-approved clinical trial study center based out of Pensacola, Fla. with offices in Mississippi, Alabama and the Florida Gulf Coast.

“Many of our patients in the Crestview, Niceville and surrounding area have had to drive to our Pensacola or Fort Walton Beach offices in order to seek treatments,” said Sunil Gupta, M.D., founder of Retina Specialty Institute.

“This new location will offer patients in these areas accessibility to more convenient treatment that will best fit their personal, transportational and scheduling needs.“

The new office, opening January 18, 2013, is located at 1299 Industrial Drive, Crestview, FL 32539. Dr. Gupta, Dr. John Myers and Dr. Ryan Tarantola and their staff are currently accepting new appointments for patients seeking treatments.

For more information regarding the new office location, including office hours and scheduling appointments, call toll-free at 1-855-5RETINA.

Through its mission of preserving, treating and advancing the science of sight, Retina Specialty Institute offers national clinical trials and state-of-the art surgical skills to patients throughout the Southeast including Pensacola, Fla., Mobile, Ala., and Hattiesburg, Miss. For more information, visit or to schedule an appointment, call 850-476-6759 or toll-free 866-293-8159.

# # #

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related medicine news :

1. Retinal Device Restores Sight to Blind Mice
2. Study finds novel therapy that may prevent damage to the retina in diabetic eye diseases
3. Prosthetic retina offers simple solution to restoring sight
4. New type of retinal prosthesis could better restore sight to blind, Stanford study says
5. Gene Signal presents data at ARVO 2012 showing topical aganirsen is active in retinal disease
6. Antibiotics Linked to Retinal Detachment Risk
7. Aesthetic Dermatology Specialty Centre Gets A Facelift
8. The JAMA Network announces new names, new embargo schedules for specialty journals
9. Leisure Fitness Opens 23rd Fitness Equipment Super Store in Paramus, NJ, Bringing Specialty Fitness Equipment and Health & Wellness to the New Jersey Fitness Community
10. Health reform: How community health centers could offer better access to subspecialty care
11. Ethics should drive health policy reform, especially with physician-owned specialty hospitals
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
Breaking Medicine Technology: